Lawyers for consumers who claim harm from tainted versions of the blood pressure-lowering drug valsartan want to expand litigation to include at least two other drugs, losartan and irbesartan.
Dozens of consumers have already filed personal-injury lawsuits around the country claiming they were diagnosed with cancer or sustained other injuries after taking valsartan contaminated with probable carcinogens.
